Literature DB >> 9508277

Understanding the discrepancies between 31P MR spectroscopy assessed liver metabolite concentrations from different institutions.

P E Sijens1, P C Dagnelie, S Halfwerk, P van Dijk, K Wicklow, M Oudkerk.   

Abstract

The high divergence between the liver metabolite concentrations and pH values reported in previous quantitative 31P magnetic resonance studies, for instance phosphomonoester (0.7-3.8 mM) and phosphodiester (3.5-9.7 mM), has not been addressed in the literature. To assess what level of discrepancy can be caused by processing and metabolite integration, in this study chemical shift imaging localized 31P magnetic resonance spectra of human liver were quantitated by three methods currently applied in clinical practice: peak areas defined manually by placement of two cursors vs. frequency domain curve fitting with the assumption of either Gaussian or Lorentzian line shapes. Large reproducible differences were found in liver metabolite peak areas but not in pH, indicating that processing and peak integration methods can only explain part of the discrepancies between the results from different institutions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9508277     DOI: 10.1016/s0730-725x(97)00246-4

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  12 in total

1.  Application of two-dimensional CSI for absolute quantification of phosphorus metabolites in the human liver.

Authors:  Z Tosner; M Dezortová; J Tintĕra; M Hájek
Journal:  MAGMA       Date:  2001-08       Impact factor: 2.310

2.  Etiology and functional status of liver cirrhosis by 31P MR spectroscopy.

Authors:  Monika Dezortova; Pavel Taimr; Antonin Skoch; Julius Spicak; Milan Hajek
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

3.  Phosphatidylcholine contributes to in vivo (31)P MRS signal from the human liver.

Authors:  Marek Chmelík; Ladislav Valkovič; Peter Wolf; Wolfgang Bogner; Martin Gajdošík; Emina Halilbasic; Stephan Gruber; Michael Trauner; Michael Krebs; Siegfried Trattnig; Martin Krššák
Journal:  Eur Radiol       Date:  2015-01-11       Impact factor: 5.315

4.  Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease.

Authors:  Bengt Norén; Peter Lundberg; Marcus Ressner; Staffan Wirell; Sven Almer; Orjan Smedby
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

5.  Hepatic fat and adenosine triphosphate measurement in overweight and obese adults using 1H and 31P magnetic resonance spectroscopy.

Authors:  Steven F Solga; Alena Horska; Susanne Hemker; Stephen Crawford; Charalett Diggs; Anna Mae Diehl; Frederick L Brancati; Jeanne M Clark
Journal:  Liver Int       Date:  2008-03-04       Impact factor: 5.828

6.  Parametric exploration of the liver by magnetic resonance methods.

Authors:  Paul E Sijens
Journal:  Eur Radiol       Date:  2009-06-06       Impact factor: 5.315

7.  Biochemical metabolic changes assessed by 31P magnetic resonance spectroscopy after radiation-induced hepatic injury in rabbits.

Authors:  Ri-Sheng Yu; Liang Hao; Fei Dong; Jian-Shan Mao; Jian-Zhong Sun; Ying Chen; Min Lin; Zhi-Kang Wang; Wen-Hong Ding
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

Review 8.  In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism.

Authors:  Ladislav Valkovič; Marek Chmelík; Martin Krššák
Journal:  Anal Biochem       Date:  2017-01-21       Impact factor: 3.365

9.  Phosphorus-31 brain MR spectroscopy in women during and after pregnancy compared with nonpregnant control subjects.

Authors:  Anita Holdcroft; Lisa Hall; Gavin Hamilton; Serena J Counsell; Graeme M Bydder; Jimmy D Bell
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

10.  Absolute Quantification of Human Liver Phosphorus-Containing Metabolites In Vivo Using an Inhomogeneous Spoiling Magnetic Field Gradient.

Authors:  Adil Bashir; Robert Gropler; Joseph Ackerman
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.